Phillip Daffas

Philip is the CEO and Managing Director of PainChek Ltd based in Sydney, Australia.

He is a highly accomplished global business leader and people manager with an international career spanning more than 25 years with leading blue-chip healthcare corporates and novel technology start-up companies.

Philip has been based in Sydney since 2001 and has held senior business leadership positions in Europe, US and Australia building businesses, growing market share and developing extensive high-level customer relationships in each sector.

Roles in Australia have included VP Global Marketing at Cochlear and General Manager with Roche Diagnostics and Bio-Rad Laboratories.

Philip’s earlier experience was gained in Europe with IVAC infusion systems and Shiley cardiopulmonary products. He joined Boehringer Mannheim, initially in the UK managing their diagnostics business and subsequently was promoted to Global Marketing Director in the Diabetes Care business based in Mannheim, Germany.

In 1997 Philip joined Cochlear in the UK as the European Sales and Marketing Manager and subsequently was promoted to VP Global Marketing based in Sydney, Australia.

Graduated in the UK with a BSc and Diploma in Electronic Engineering, Philip also has an MBA and is a Member of the Australian Institute of Company Directors.


PainChek – The evolution of pain assessment

1. The issues around pain in people that are cognitively impaired, 

2. FACs coding, identifying pain in people that can’t verbalize they are in pain,

 3. PainChek – a binary assessment tool,

 4. PainChek overview